Hawkins Richard J 4
4 · LUMOS PHARMA, INC. · Filed Dec 13, 2024
Insider Transaction Report
Form 4
LUMOS PHARMA, INC.(LUMO)
Hawkins Richard J
DirectorChief Executive Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−28,475→ 0 totalExercise: $17.35Exp: 2031-01-31→ Common Stock (28,475 underlying) - Disposition to Issuer
Common Stock
2024-12-12−753,093→ 0 total - Disposition to Issuer
Common Stock
2024-12-12−4,469→ 0 total(indirect: By Trust) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−135,000→ 0 totalExercise: $7.87Exp: 2030-03-31→ Common Stock (135,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−19,624→ 0 totalExercise: $1.84Exp: 2029-06-27→ Common Stock (19,624 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−35,400→ 0 totalExercise: $2.84Exp: 2034-03-31→ Common Stock (35,400 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−35,400→ 0 totalExercise: $3.52→ Common Stock (35,400 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−35,400→ 0 totalExercise: $10.02Exp: 2032-01-31→ Common Stock (35,400 underlying)
Footnotes (3)
- [F1]Disposed of pursuant to that certain Agreement and Plan of Merger, dated October 22, 2024, by and between the Issuer, DPV Parent, Inc., DPV MergerSub, Inc. and Double Point Ventures LLC ("DPV") (the "Merger Agreement") in exchange for (i) $4.25 in cash per share (the "Cash Amount"), plus (ii) one non-transferable contingent value right ("CVR") per share. Each restricted stock unit ("RSU") was cancelled and will receive the Cash Amount plus one CVR per RSU.
- [F2]This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option.
- [F3]Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement.